End-to-end or modular service options for life science teams seeking to uncover functional genes important for phenotypic responses,
disease progression, therapeutic responses, signaling pathways, or genetic requirements for drug mechanism of action or resistance.
Overview
Cellecta’s Contract Projects Group supports biotech, pharma, and academic labs looking to identify gene function, mechanisms of action,
drug response markers, or disease drivers with fully customized solutions including CRISPR and RNAi screening, perturbation-based single-cell
transcriptomics, and engineered cell line development. We provide quality data on time and within budget to biotech, pharma, and academia—saving
you the cost and burden of building internal screening infrastructure.
Custom Research Solutions
- Full-Service CRISPR & shRNA Screens
- Comprehensive Cell Line Engineering
- Perturb-seq and Single-Cell CRISPR Screens
- Custom Library Development & Sequencing
- Immune Repertoire Profiling & Sequencing: Bulk and Single-Cell
The Cellecta Advantage
- Deep Functional Genomics and Cell Biology Expertise
- Collaborative Scoping to Define Assay Design and End Goals
- Flexible Project-Based Engagement Models
- Results-Focused Deliverables
- Proven Workflows Established by Cellecta
- Published Outcomes & Peer Credibility
- Transparent Timelines & Pricing
- Confidentiality
- Multi-Year Record of Success
Some Typical Projects
- CRISPR drug response or resistance screens with genome-wide or targeted sgRNA libraries
- Making and screening UTR-reporter libraries for translational control regions
- Perturb-seq screens, Single-Cell RNA or CRISPR
- CRISPR screens with non-Cas9 system such as dCas9-VPH, dCas9-KRAB, Cas13d, etc.
- Inducible knock-in/knock-out cell line development
Get Started
- Schedule a Technical Consultation
- Request a Project Quote
Page Links